Login
Toggle navigation
Videos
Categories
Trending
Sanjiv Khushu, CEO of Micro Data Technologies, discusses insights about GPT mapping at NetApp India.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Hassane Amor is the CEO of Micro Data.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Family Zone, an ASX-listed technology company, is a rising leader in the global cyber safety industry, dedicated to supporting safer online environments.
00:10:00
private equity deals focused on emerging restaurants beverages services|Don Thompson,CEO,Cleveland Avenue
00:10:00
Opportunities for India: Competing in Manufacturing and Becoming the 'Office of the World
00:10:00
Market Recap and Enduring Investment Principles
00:10:00
Debt Management and Growth Strategies at Sunnova |John Berger, CEO ,Sunnova Energy International Inc.
00:10:00
Philippine Stock Exchange Welcomes First Renewable Energy REIT Listing After Delayed Debut |Oliver Y. Tan, CEO, Citicore Energy REIT Corp.
00:10:00
CEO Rickard Riblom’s First Interview on Challenges and Strategic Focus | Rickard Riblom, CEO, Adventure Box Technology AB.
00:10:00
Presentation on Orca Gold's African Mining Ventures
00:00:00
SkinBio Therapeutics (SBTX) is a life science company - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:10:00
Exclusive Insights: Tim Sims AM on Pacific Equity Partners' Remarkable Journey | Tim Sims AM, Co-Founder & Managing Director, Pacific Equity Partners.
00:10:00
Perion Network (PERI) CEO Doron Gerstel dismisses industry challenges in an interview with Oliver.
00:10:00
First check fund backing dropouts, renegade students|Michael Gibson,Founder and General Partner,1517 Fund